除颤阈值测试有作用吗？一例心脏淀粉样变性患者发生对植入式心脏复律除颤器电击耐受的心室颤动 - Suppr

Suppr

超能文献

A role for defibrillation threshold testing? A case of ventricular fibrillation refractory to implantable cardioverter-defibrillator shocks in setting of cardiac amyloidosis.

作者信息

Lee Tyler, Marinchak Roger

机构信息

Jefferson Abington Hospital, Abington, Pennsylvania.

出版信息

HeartRhythm Case Rep. 2025 Mar 3;11(5):492-495. doi: 10.1016/j.hrcr.2025.02.020. eCollection 2025 May.

DOI:10.1016/j.hrcr.2025.02.020

PMID:40656007

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12242980/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab58/12242980/33aa4d9a4721/gr1.jpg

相似文献

A role for defibrillation threshold testing? A case of ventricular fibrillation refractory to implantable cardioverter-defibrillator shocks in setting of cardiac amyloidosis.

HeartRhythm Case Rep. 2025 Mar 3;11(5):492-495. doi: 10.1016/j.hrcr.2025.02.020. eCollection 2025 May.

Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30.

Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.

J Am Coll Cardiol. 1996 Apr;27(5):1112-8. doi: 10.1016/0735-1097(95)00603-6.

Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.

Arch Intern Med. 1989 Oct;149(10):2333-9.

Catheter Ablation of Ventricular Arrhythmia in Patients With an Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-analysis.

Can J Cardiol. 2023 Mar;39(3):250-262. doi: 10.1016/j.cjca.2022.12.004. Epub 2022 Dec 12.

Usefulness of lead repositioning from left to right sternal border for a patient with subcutaneous implantable cardioverter defibrillator showing high defibrillation threshold.

J Arrhythm. 2018 Dec 7;35(1):133-135. doi: 10.1002/joa3.12145. eCollection 2019 Feb.

Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery.

Europace. 2012 Jun;14(6):853-8. doi: 10.1093/europace/eus013. Epub 2012 Feb 14.

STEPWISE CARDIAC REHABILITATION ADJUSTMENT AFTER EXERCISE-INDUCED IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCK: A CASE REPORT.

J Rehabil Med Clin Commun. 2025 Apr 16;8:42483. doi: 10.2340/jrm-cc.v8.42483. eCollection 2025.

Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications.

Heart Rhythm. 2016 Feb;13(2):443-54. doi: 10.1016/j.hrthm.2015.09.010. Epub 2015 Sep 15.

Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator.

JACC Clin Electrophysiol. 2018 May;4(5):652-659. doi: 10.1016/j.jacep.2017.11.019. Epub 2018 Feb 2.

本文引用的文献

Infiltration of Conduction Tissue Is a Major Cause of Electrical Instability in Cardiac Amyloidosis.

J Clin Med. 2023 Feb 23;12(5):1798. doi: 10.3390/jcm12051798.

A case of AL amyloidosis presenting with refractory ventricular fibrillation.

Respir Med Case Rep. 2021 Jan 24;32:101349. doi: 10.1016/j.rmcr.2021.101349. eCollection 2021.

Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator.

Europace. 2020 Aug 1;22(8):1216-1223. doi: 10.1093/europace/euaa094.

Coronary vein defibrillator coil placement in patients with high defibrillation thresholds.

J Arrhythm. 2018 Dec 3;35(1):79-85. doi: 10.1002/joa3.12136. eCollection 2019 Feb.

Defibrillation Threshold Testing: Current Status.

Arrhythm Electrophysiol Rev. 2018 Dec;7(4):288-293. doi: 10.15420/aer.2018.54.2.

Azygos vein lead implantation for high defibrillation thresholds in implantable cardioverter defibrillator placement.

Indian Pacing Electrophysiol J. 2010 Jan 7;10(1):49-54.

Cardiac amyloidosis treated with an implantable cardioverter defibrillator and subcutaneous array lead system: report of a case and literature review.

Clin Cardiol. 2009 Aug;32(8):E63-5. doi: 10.1002/clc.20389.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验